COCRYSTAL PHARMA, INC. Research and Development Expense
COCRYSTAL PHARMA, INC. (COCP) reported Research and Development Expense of $2.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. research and development expense for the quarter ending 2026-06-30 was $2.14M, a 90.91% increase year-over-year.
- COCRYSTAL PHARMA, INC. research and development expense for the quarter ending 2026-03-31 was $1.37M, a 0.81% increase year-over-year.
- COCRYSTAL PHARMA, INC. research and development expense for the quarter ending 2025-12-31 was $1.62M, a 20.52% decline year-over-year.
- COCRYSTAL PHARMA, INC. research and development expense for the quarter ending 2025-09-30 was $954.00K, a 70.57% decline year-over-year.
- COCRYSTAL PHARMA, INC. research and development expense for fiscal 2025 was $5.05M, a 59.68% decline from fiscal 2024.
- COCRYSTAL PHARMA, INC. research and development expense for fiscal 2024 was $12.54M, a 17.35% decline from fiscal 2023.
- COCRYSTAL PHARMA, INC. research and development expense for fiscal 2023 was $15.17M, a 22.41% increase from fiscal 2022.
- COCRYSTAL PHARMA, INC. research and development expense for fiscal 2022 was $12.39M, a 40.91% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 87 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.14M 10-Q · filed 2026-08-13 | $3.51M 10-Q · filed 2026-08-13 | $5.13M derived: sum of 3 quarters · filed 2026-08-13 | $6.09M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $1.37M 10-Q · filed 2026-05-15 | $2.99M derived: sum of 2 quarters · filed 2026-05-15 | $3.94M derived: sum of 3 quarters · filed 2026-05-15 | $5.07M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.57M derived: sum of 2 quarters · filed 2026-03-31 | $3.69M derived: sum of 3 quarters · filed 2026-08-13 | $5.05M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $954.00K 10-Q · filed 2025-11-14 | $2.08M derived: sum of 2 quarters · filed 2026-08-13 | $3.44M 10-Q · filed 2025-11-14 | $5.47M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $1.12M 10-Q · filed 2026-08-13 | $2.48M 10-Q · filed 2026-08-13 | $4.52M derived: sum of 3 quarters · filed 2026-08-13 | $7.76M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $1.36M 10-Q · filed 2026-05-15 | $3.40M derived: sum of 2 quarters · filed 2026-05-15 | $6.64M derived: sum of 3 quarters · filed 2026-05-15 | $10.95M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.28M derived: sum of 2 quarters · filed 2026-03-31 | $9.59M derived: sum of 3 quarters · filed 2026-03-31 | $12.54M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $3.24M 10-Q · filed 2025-11-14 | $7.55M derived: sum of 2 quarters · filed 2025-11-14 | $10.50M 10-Q · filed 2025-11-14 | $14.77M derived: sum of 4 quarters · filed 2025-11-14 | |||||
| 2024-06-30 | $4.31M 10-Q · filed 2025-08-14 | $7.26M 10-Q · filed 2025-08-14 | $11.53M derived: sum of 3 quarters · filed 2025-08-14 | $15.72M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $2.95M 10-Q · filed 2025-05-15 | $7.22M derived: sum of 2 quarters · filed 2025-05-15 | $11.41M derived: sum of 3 quarters · filed 2025-05-15 | $14.21M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $8.46M derived: sum of 2 quarters · filed 2025-03-31 | $11.26M derived: sum of 3 quarters · filed 2025-03-31 | $15.17M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $4.19M 10-Q · filed 2024-11-13 | $7.00M derived: sum of 2 quarters · filed 2024-11-13 | $10.90M 10-Q · filed 2024-11-13 | $14.19M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $2.80M 10-Q · filed 2024-08-14 | $6.71M 10-Q · filed 2024-08-14 | $9.99M derived: sum of 3 quarters · filed 2024-08-14 | $13.87M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $3.91M 10-Q · filed 2024-05-13 | $7.19M derived: sum of 2 quarters · filed 2024-05-13 | $11.07M derived: sum of 3 quarters · filed 2024-05-13 | $13.43M derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $7.16M derived: sum of 2 quarters · filed 2024-03-28 | $9.52M derived: sum of 3 quarters · filed 2024-03-28 | $12.39M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $3.87M 10-Q · filed 2023-11-13 | $6.23M derived: sum of 2 quarters · filed 2023-11-13 | $9.11M 10-Q · filed 2023-11-13 | $11.84M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $2.36M 10-Q · filed 2023-08-14 | $5.23M 10-Q · filed 2023-08-14 | $7.97M derived: sum of 3 quarters · filed 2023-08-14 | $10.07M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $2.87M 10-Q · filed 2023-05-15 | $5.61M derived: sum of 2 quarters · filed 2023-05-15 | $7.71M derived: sum of 3 quarters · filed 2023-05-15 | $10.27M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $4.84M derived: sum of 2 quarters · filed 2023-03-29 | $7.39M derived: sum of 3 quarters · filed 2023-03-29 | $8.79M 10-K · filed 2023-03-29 | |||||
| 2021-09-30 | $2.10M 10-Q · filed 2022-11-14 | $2.17M 10-Q · filed 2021-11-15 | $4.66M derived: sum of 2 quarters · filed 2022-11-14 | $6.06M 10-Q · filed 2022-11-14 | $6.49M 10-Q · filed 2021-11-15 | $6.94M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $2.56M 10-Q · filed 2022-08-15 | $2.75M 10-Q · filed 2021-08-16 | $3.96M 10-Q · filed 2022-08-15 | $4.32M 10-Q · filed 2021-08-16 | $4.83M derived: sum of 3 quarters · filed 2022-08-15 | $6.91M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-11 | $2.27M derived: sum of 2 quarters · filed 2022-05-11 | $4.35M derived: sum of 3 quarters · filed 2022-05-11 | $6.33M derived: sum of 4 quarters · filed 2022-05-11 | |||||
| 2020-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $2.77M derived: sum of 2 quarters · filed 2022-03-23 | $4.75M derived: sum of 3 quarters · filed 2022-03-23 | $6.03M 10-K · filed 2022-03-23 | $6.31M 10-K · filed 2021-03-17 | ||||
| 2020-09-30 | $2.08M 10-Q · filed 2021-11-15 | $4.05M derived: sum of 2 quarters · filed 2021-11-15 | $5.34M 10-Q · filed 2021-11-15 | $6.29M derived: sum of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | $1.98M 10-Q · filed 2021-08-16 | $3.26M 10-Q · filed 2021-08-16 | $4.22M derived: sum of 3 quarters · filed 2021-08-16 | $5.29M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2020-03-31 | $1.28M 10-Q · filed 2021-05-17 | $2.24M derived: sum of 2 quarters · filed 2021-05-17 | $3.32M derived: sum of 3 quarters · filed 2021-05-17 | $4.41M derived: sum of 4 quarters · filed 2021-05-17 | |||||
| 2019-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $2.04M derived: sum of 2 quarters · filed 2021-03-17 | $3.13M derived: sum of 3 quarters · filed 2021-03-17 | $4.00M 10-K · filed 2021-03-17 | |||||
| 2019-09-30 | $1.08M 10-Q · filed 2020-11-13 | $2.17M derived: sum of 2 quarters · filed 2020-11-13 | $3.05M 10-Q · filed 2020-11-13 | $4.25M derived: sum of 4 quarters · filed 2020-11-13 | |||||
| 2019-06-30 | $1.09M 10-Q · filed 2020-08-06 | $1.97M 10-Q · filed 2020-08-06 | $3.17M derived: sum of 3 quarters · filed 2020-08-06 | $4.64M derived: sum of 4 quarters · filed 2020-08-06 | |||||
| 2019-03-31 | $878.00K 10-Q · filed 2020-05-13 | $2.08M derived: sum of 2 quarters · filed 2020-05-13 | $3.55M derived: sum of 3 quarters · filed 2020-05-13 | $4.67M derived: sum of 4 quarters · filed 2020-05-13 | |||||
| 2018-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.67M derived: sum of 2 quarters · filed 2020-03-27 | $3.79M derived: sum of 3 quarters · filed 2020-03-27 | $4.67M 10-K · filed 2020-03-27 | $58.57M 10-K · filed 2019-04-01 | ||||
| 2018-09-30 | $1.47M 10-Q · filed 2019-11-12 | $2.59M derived: sum of 2 quarters · filed 2019-11-12 | $3.46M 10-Q · filed 2019-11-12 | $4.57M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | $1.12M 10-Q · filed 2019-08-09 | $2.00M 10-Q · filed 2019-08-09 | $3.10M derived: sum of 3 quarters · filed 2019-08-09 | $4.49M derived: sum of 4 quarters · filed 2019-08-09 | |||||
| 2018-03-31 | $877.00K 10-Q · filed 2019-05-10 | $1.98M derived: sum of 2 quarters · filed 2019-05-10 | $3.37M derived: sum of 3 quarters · filed 2019-05-10 | $4.77M derived: sum of 4 quarters · filed 2019-05-10 | |||||
| 2017-12-31 | $1.10M 10-K · filed 2018-03-21 | $2.50M derived: sum of 2 quarters · filed 2018-03-21 | $3.89M derived: sum of 3 quarters · filed 2018-11-09 | $5.82M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $1.39M 10-K · filed 2018-03-21 | $2.79M derived: sum of 2 quarters · filed 2018-11-09 | $4.72M 10-Q · filed 2018-11-09 | $98.73M derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | $1.39M 10-Q · filed 2018-11-09 | $1.25M 10-Q · filed 2017-08-08 | $3.33M 10-Q · filed 2018-08-09 | $97.34M derived: sum of 3 quarters · filed 2018-11-09 | $99.43M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-03-31 | $2.07M 10-Q · filed 2018-05-10 | $95.95M derived: sum of 2 quarters · filed 2018-05-10 | $98.04M derived: sum of 3 quarters · filed 2018-05-10 | $100.41M derived: sum of 4 quarters · filed 2018-05-10 | |||||
| 2016-12-31 | $93.88M 10-K · filed 2018-03-21 | $95.97M derived: sum of 2 quarters · filed 2018-03-21 | $98.34M derived: sum of 3 quarters · filed 2018-03-21 | $101.68M 10-K · filed 2018-03-21 | |||||
| 2016-09-30 | $2.09M 10-K · filed 2018-03-21 | $4.46M derived: sum of 2 quarters · filed 2018-03-21 | $7.80M 10-Q · filed 2017-11-08 | $46.50M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2016-06-30 | $2.37M 10-K · filed 2018-03-21 | $5.71M 10-Q · filed 2017-08-08 | $44.41M derived: sum of 3 quarters · filed 2018-03-21 | $46.59M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2016-03-31 | $3.34M 10-K · filed 2018-03-21 | $42.04M derived: sum of 2 quarters · filed 2018-03-21 | $44.22M derived: sum of 3 quarters · filed 2018-03-21 | $46.16M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2015-12-31 | $38.70M 10-K · filed 2018-03-21 | $41.58M 10-K · filed 2017-03-31 | $40.88M derived: sum of 2 quarters · filed 2018-03-21 | $42.82M derived: sum of 3 quarters · filed 2018-03-21 | $47.26M 10-K · filed 2018-03-21 | ||||
| 2015-09-30 | $2.18M 10-K · filed 2017-03-31 | $4.12M derived: sum of 2 quarters · filed 2017-03-31 | $5.75M 10-Q · filed 2016-11-09 | $7.03M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-06-30 | $1.95M 10-K · filed 2017-03-31 | $3.50M 10-Q · filed 2016-08-09 | $4.86M derived: sum of 3 quarters · filed 2017-03-31 | $5.72M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-03-31 | $1.56M 10-K · filed 2017-03-31 | $2.91M derived: sum of 2 quarters · filed 2017-03-31 | $3.77M derived: sum of 3 quarters · filed 2017-03-31 | $4.66M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2014-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.21M derived: sum of 2 quarters · filed 2017-03-31 | $3.10M derived: sum of 3 quarters · filed 2017-03-31 | $4.07M 10-K · filed 2017-03-31 | |||||
| 2014-09-30 | $866.00K 10-Q · filed 2015-11-16 | $1.75M derived: sum of 2 quarters · filed 2015-11-16 | $2.72M 10-Q · filed 2015-11-16 | $3.65M derived: sum of 4 quarters · filed 2015-11-16 | |||||
| 2014-06-30 | $888.00K 10-Q · filed 2015-08-14 | $1.85M 10-Q · filed 2015-08-14 | $2.78M derived: sum of 3 quarters · filed 2015-08-14 | $3.73M derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $967.00K 10-Q · filed 2015-05-14 | $1.89M derived: sum of 2 quarters · filed 2015-05-14 | $2.84M derived: sum of 3 quarters · filed 2015-05-14 | $3.82M derived: sum of 4 quarters · filed 2015-05-14 | $16.47M 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $1.88M derived: sum of 2 quarters · filed 2015-03-31 | $2.86M derived: sum of 3 quarters · filed 2015-03-31 | $3.86M 10-K · filed 2015-03-31 | $17.50K 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | $950.00K 10-Q · filed 2014-11-14 | $55.39K 10-Q · filed 2013-11-18 | $1.93M derived: sum of 2 quarters · filed 2014-11-14 | $2.94M 10-Q · filed 2014-11-14 | $81.07K 10-Q · filed 2013-11-18 | $2.84M derived: sum of 4 quarters · filed 2014-11-14 | |||
| 2013-06-30 | $980.00K 10-Q · filed 2014-08-14 | $5.84K 10-Q · filed 2013-08-15 | $1.99M 10-Q · filed 2014-08-14 | $25.68K 10-Q · filed 2013-08-15 | $1.89M derived: sum of 3 quarters · filed 2014-08-14 | $2.05M derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | $1.00M 10-Q · filed 2014-05-15 | $19.83K 10-Q · filed 2013-05-10 | $910.29K derived: sum of 2 quarters · filed 2014-05-15 | $1.07M derived: sum of 3 quarters · filed 2014-05-15 | $1.27M derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | -$94.71K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $61.23K derived: sum of 2 quarters · filed 2014-03-31 | $267.73K derived: sum of 3 quarters · filed 2014-03-31 | $489.35K 10-K · filed 2014-03-31 | $743.09K 10-K · filed 2013-04-01 | ||||
| 2012-09-30 | $155.94K 10-Q · filed 2013-11-18 | $362.44K derived: sum of 2 quarters · filed 2013-11-18 | $584.06K 10-Q · filed 2013-11-18 | $888.08K derived: sum of 4 quarters · filed 2013-11-18 | |||||
| 2012-06-30 | $206.50K 10-Q · filed 2013-08-15 | $428.12K 10-Q · filed 2013-08-15 | $732.13K derived: sum of 3 quarters · filed 2013-08-15 | $736.14K derived: sum of 4 quarters · filed 2013-08-15 | |||||
| 2012-03-31 | $221.61K 10-Q · filed 2013-05-10 | $525.63K derived: sum of 2 quarters · filed 2013-05-10 | $529.64K derived: sum of 3 quarters · filed 2013-05-10 | $583.03K derived: sum of 4 quarters · filed 2013-05-10 | |||||
| 2011-12-31 | $304.02K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $308.03K derived: sum of 2 quarters · filed 2013-04-01 | $361.42K derived: sum of 3 quarters · filed 2013-04-01 | $423.18K 10-K · filed 2013-04-01 | $399.62K 10-K · filed 2012-04-16 | ||||
| 2011-09-30 | $4.01K 10-Q · filed 2012-11-14 | $57.40K derived: sum of 2 quarters · filed 2012-11-14 | $119.17K 10-Q · filed 2012-11-14 | $213.65K derived: sum of 4 quarters · filed 2012-11-14 | |||||
| 2011-06-30 | $53.39K 10-Q/A · filed 2012-09-28 | $115.16K 10-Q/A · filed 2012-09-28 | $209.63K derived: sum of 3 quarters · filed 2012-10-02 | $264.47K derived: sum of 4 quarters · filed 2012-10-02 | |||||
| 2011-03-31 | $64.87K 10-Q/A · filed 2012-10-02 | $156.24K derived: sum of 2 quarters · filed 2012-10-02 | $211.08K derived: sum of 3 quarters · filed 2012-10-02 | $255.25K derived: sum of 4 quarters · filed 2012-10-02 | |||||
| 2010-12-31 | $91.38K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $146.21K derived: sum of 2 quarters · filed 2012-04-16 | $190.39K derived: sum of 3 quarters · filed 2012-04-16 | $240.87K 10-K · filed 2012-04-16 | |||||
| 2010-09-30 | $54.84K 10-Q · filed 2011-11-21 | $99.01K derived: sum of 2 quarters · filed 2011-11-21 | $149.50K 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $44.17K 10-Q/A · filed 2011-09-09 | $94.66K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |